Evidence map›Paper›PMID 39712843›Full record

ArticleCureus2024

Chronic Lymphocytic Leukemia Infiltrating in the Brain.

Lauren M Webb, Saad S Kenderian, Allison M Angeli, Matthew T Howard, Eelco F Wijdicks

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lauren M WebbNeurology, Mayo Clinic, Rochester, USA.
Saad S KenderianHematology, Mayo Clinic, Rochester, USA.
Allison M AngeliInternal Medicine, Mayo Clinic, Rochester, USA.
Matthew T HowardHematopathology, Mayo Clinic, Rochester, USA.
Eelco F WijdicksNeurology, Mayo Clinic, Rochester, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While earlier post-mortem studies show involvement of the central nervous system in 71% of patients with chronic lymphocytic leukemia (CLL), involvement intravitam is rare. A 72-year-old man with untreated, minimally symptomatic CLL developed subacute-onset encephalopathy and presented with severe hyponatremia and stress-induced cardiomyopathy. His initial head computed tomography scan was unremarkable. His mental status did not improve with careful sodium correction. Magnetic resonance imaging of the brain eventually revealed widespread T2 hyperintensities throughout the cerebral hemispheres, brainstem, and cerebellum. A cerebrospinal fluid analysis demonstrated elevated total nucleated cells (31/mcL, 89% lymphocytes), protein of 75 mg/dL, positive human herpesvirus 6 by polymerase chain reaction, and the presence of malignant CD5+ B cells, consistent with CLL. Brain biopsy confirmed direct infiltration of CLL cells in the brain parenchyma. He was started on zanubrutinib, which led to clinical and radiologic improvement. His neurologic recovery remained slow, and his family elected to transition to comfort-focused care. Our patient's case exemplifies a rare neurologic manifestation affecting <1% of patients with CLL. Despite partial clinical and radiologic response to zanubrutinib, he had a poor outcome, likely due to the extensive brain areas involved by CLL.

Indexed as

brain biopsychronic lymphocytic leukemia (cll)encephalopathyneuro-oncologyradiology

Identifiers

PMID39712843
PMCPMC11660725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.